GMO Product Platform (3695) 주식 개요는 일본, 아시아 및 전 세계에 오디언스 참여 플랫폼을 제공합니다. 자세히 보기3695 펀더멘털 분석스노우플레이크 점수가치 평가2/6미래 성장0/6과거 실적4/6재무 건전성5/6배당5/6강점공정 가치 추정치보다 낮은 69.2% 에서 거래지난 1년간 수익이 1625% 증가했습니다.위험 분석지난 5년간 매년 수익이 11.7% 감소했습니다.의미 있는 시가총액이 없습니다(¥7B)불안정한 배당 실적모든 위험 점검 보기3695 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueJP¥Current PriceJP¥1.61k22.9% 저평가 내재 할인율Growth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture012b2016201920222025202620282031Revenue JP¥12.4bEarnings JP¥682.8mAdvancedSet Fair ValueView all narrativesGMO Product Platform, Inc. 경쟁사InterspaceLtdSymbol: TSE:2122Market cap: JP¥7.9bKyodo Public RelationsSymbol: TSE:2436Market cap: JP¥8.9bOrchestra HoldingsSymbol: TSE:6533Market cap: JP¥9.0bGMO TECH HoldingsSymbol: TSE:415AMarket cap: JP¥7.5b가격 이력 및 성과GMO Product Platform 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가JP¥1,614.0052주 최고가JP¥2,775.0052주 최저가JP¥1,582.00베타0.0261개월 변동-7.72%3개월 변동-6.43%1년 변동-34.95%3년 변동-50.34%5년 변동-34.12%IPO 이후 변동-66.58%최근 뉴스 및 업데이트Reported Earnings • May 13First quarter 2026 earnings released: EPS: JP¥43.61 (vs JP¥41.01 loss in 1Q 2025)First quarter 2026 results: EPS: JP¥43.61 (up from JP¥41.01 loss in 1Q 2025). Revenue: JP¥2.00b (up 52% from 1Q 2025). Net income: JP¥192.0m (up JP¥259.0m from 1Q 2025). Profit margin: 9.6% (up from net loss in 1Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Feb 17Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to JP¥1,706, the stock trades at a trailing P/E ratio of 48.5x. Average trailing P/E is 16x in the Media industry in Japan. Total loss to shareholders of 38% over the past three years.New Risk • Feb 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (170% increase in shares outstanding). Minor Risks Dividend is not well covered by earnings (158% payout ratio). Share price has been volatile over the past 3 months (5.5% average weekly change). Profit margins are more than 30% lower than last year (2.3% net profit margin). Market cap is less than US$100m (JP¥8.10b market cap, or US$52.8m).Reported Earnings • Feb 11Full year 2025 earnings released: EPS: JP¥41.66 (vs JP¥112 in FY 2024)Full year 2025 results: EPS: JP¥41.66 (down from JP¥112 in FY 2024). Revenue: JP¥6.82b (up 36% from FY 2024). Net income: JP¥155.0m (down 15% from FY 2024). Profit margin: 2.3% (down from 3.6% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.New Risk • Feb 11New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.3% Last year net profit margin: 3.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (170% increase in shares outstanding). Minor Risks Dividend is not well covered by earnings (158% payout ratio). Profit margins are more than 30% lower than last year (2.3% net profit margin). Market cap is less than US$100m (JP¥9.03b market cap, or US$59.0m).공시 • Feb 10GMO Product Platform, Inc., Annual General Meeting, Mar 17, 2026GMO Product Platform, Inc., Annual General Meeting, Mar 17, 2026.더 많은 업데이트 보기Recent updatesReported Earnings • May 13First quarter 2026 earnings released: EPS: JP¥43.61 (vs JP¥41.01 loss in 1Q 2025)First quarter 2026 results: EPS: JP¥43.61 (up from JP¥41.01 loss in 1Q 2025). Revenue: JP¥2.00b (up 52% from 1Q 2025). Net income: JP¥192.0m (up JP¥259.0m from 1Q 2025). Profit margin: 9.6% (up from net loss in 1Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Feb 17Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to JP¥1,706, the stock trades at a trailing P/E ratio of 48.5x. Average trailing P/E is 16x in the Media industry in Japan. Total loss to shareholders of 38% over the past three years.New Risk • Feb 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (170% increase in shares outstanding). Minor Risks Dividend is not well covered by earnings (158% payout ratio). Share price has been volatile over the past 3 months (5.5% average weekly change). Profit margins are more than 30% lower than last year (2.3% net profit margin). Market cap is less than US$100m (JP¥8.10b market cap, or US$52.8m).Reported Earnings • Feb 11Full year 2025 earnings released: EPS: JP¥41.66 (vs JP¥112 in FY 2024)Full year 2025 results: EPS: JP¥41.66 (down from JP¥112 in FY 2024). Revenue: JP¥6.82b (up 36% from FY 2024). Net income: JP¥155.0m (down 15% from FY 2024). Profit margin: 2.3% (down from 3.6% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.New Risk • Feb 11New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.3% Last year net profit margin: 3.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (170% increase in shares outstanding). Minor Risks Dividend is not well covered by earnings (158% payout ratio). Profit margins are more than 30% lower than last year (2.3% net profit margin). Market cap is less than US$100m (JP¥9.03b market cap, or US$59.0m).공시 • Feb 10GMO Product Platform, Inc., Annual General Meeting, Mar 17, 2026GMO Product Platform, Inc., Annual General Meeting, Mar 17, 2026.공시 • Dec 27GMO Product Platform, Inc. to Report Fiscal Year 2025 Results on Feb 10, 2026GMO Product Platform, Inc. announced that they will report fiscal year 2025 results on Feb 10, 2026Upcoming Dividend • Dec 22Upcoming dividend of JP¥34.58 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 23 March 2026. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 1.6%. Lower than top quartile of Japanese dividend payers (3.6%). In line with average of industry peers (1.7%).공시 • Dec 17GMO Product Platform, Inc. (TSE:3695) agreed to acquire 53.60% stake in STOCK POINT Inc. from Credit Saison Co., Ltd. (TSE:8253), KITS Co., Ltd and Kiyomi Tsuchiya for approximately ¥360 million.GMO Product Platform, Inc. (TSE:3695) agreed to acquire 53.60% stake in STOCK POINT Inc. from Credit Saison Co., Ltd. (TSE:8253), KITS Co., Ltd and Kiyomi Tsuchiya for approximately ¥360 million on December 15, 2025. A cash consideration of ¥361 million will be paid by GMO Product Platform, Inc. The scheduled contract execution date is December 16, 2025. Prior to the share transfer execution date, we may acquire additional shares of STOCK POINT Inc. held by other individuals and corporations. In this case, the maximum acquisition price will be ¥564 million, and the maximum number of shares to be acquired will be 1,324 shares and the maximum ownership ratio will be 82.5%. Additional disclosure is planned once the acquisition price and number of shares for the additional acquisition are finalized. For the period ending March 31, 2025, STOCK POINT Inc. reported total revenue of ¥374.18 million, operating loss of ¥231.81 million and net income of ¥200.21 million. As of March 31, 2025, STOCK POINT Inc. reported total assets of ¥2.28 billion and total common equity of ¥214.51 million. The expected completion of the transaction is December 26, 2025.Buy Or Sell Opportunity • Dec 04Now 21% overvaluedOver the last 90 days, the stock has fallen 2.4% to JP¥2,159. The fair value is estimated to be JP¥1,782, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.4% over the last 3 years. Earnings per share has declined by 48%.Reported Earnings • Nov 15Third quarter 2025 earnings released: EPS: JP¥23.99 (vs JP¥8.57 loss in 3Q 2024)Third quarter 2025 results: EPS: JP¥23.99 (up from JP¥8.57 loss in 3Q 2024). Revenue: JP¥1.75b (up 47% from 3Q 2024). Net income: JP¥106.0m (up JP¥120.0m from 3Q 2024). Profit margin: 6.1% (up from net loss in 3Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.공시 • Sep 17GMO Research & AI, Inc. to Report Q3, 2025 Results on Nov 12, 2025GMO Research & AI, Inc. announced that they will report Q3, 2025 results on Nov 12, 2025Reported Earnings • Aug 08Second quarter 2025 earnings released: EPS: JP¥12.67 (vs JP¥12.24 loss in 2Q 2024)Second quarter 2025 results: EPS: JP¥12.67 (up from JP¥12.24 loss in 2Q 2024). Revenue: JP¥1.85b (up 68% from 2Q 2024). Net income: JP¥56.0m (up JP¥76.0m from 2Q 2024). Profit margin: 3.0% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.공시 • Jun 27GMO Research & AI, Inc. to Report Q2, 2025 Results on Aug 07, 2025GMO Research & AI, Inc. announced that they will report Q2, 2025 results on Aug 07, 2025New Risk • May 17New major risk - Revenue and earnings growthEarnings have declined by 0.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Dividend per share is over 7x earnings per share. Cash payout ratio: 447% Earnings have declined by 0.4% per year over the past 5 years. Shareholders have been substantially diluted in the past year (169% increase in shares outstanding). Minor Risks Profit margins are more than 30% lower than last year (0.5% net profit margin). Market cap is less than US$100m (JP¥11.1b market cap, or US$76.0m).Reported Earnings • May 17First quarter 2025 earnings released: JP¥41.01 loss per share (vs JP¥56.35 profit in 1Q 2024)First quarter 2025 results: JP¥41.01 loss per share (down from JP¥56.35 profit in 1Q 2024). Revenue: JP¥1.32b (down 3.2% from 1Q 2024). Net loss: JP¥67.0m (down 173% from profit in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has remained flat, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • May 15Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to JP¥2,374, the stock trades at a trailing P/E ratio of 57.1x. Average trailing P/E is 17x in the Media industry in Japan. Total returns to shareholders of 4.5% over the past three years.New Risk • Apr 18New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 169% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 103% Cash payout ratio: 447% Shareholders have been substantially diluted in the past year (169% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Profit margins are more than 30% lower than last year (3.6% net profit margin). Market cap is less than US$100m (JP¥12.2b market cap, or US$85.7m).분석 기사 • Apr 09Returns On Capital At GMO Research & AI (TSE:3695) Paint A Concerning PictureWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...공시 • Mar 08GMO Research & AI, Inc. to Report Q1, 2025 Results on May 12, 2025GMO Research & AI, Inc. announced that they will report Q1, 2025 results on May 12, 2025New Risk • Feb 15New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 127% Cash payout ratio: 166% Dividend yield: 4.1% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.6% average weekly change). Dividend is not well covered by earnings and cash flows. Payout ratio: 127% Cash payout ratio: 166% Minor Risks Profit margins are more than 30% lower than last year (3.6% net profit margin). Market cap is less than US$100m (JP¥4.57b market cap, or US$30.0m).Reported Earnings • Feb 14Full year 2024 earnings released: EPS: JP¥112 (vs JP¥188 in FY 2023)Full year 2024 results: EPS: JP¥112 (down from JP¥188 in FY 2023). Revenue: JP¥5.03b (down 1.8% from FY 2023). Net income: JP¥183.0m (down 40% from FY 2023). Profit margin: 3.6% (down from 6.0% in FY 2023). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.분석 기사 • Feb 13GMO Research & AI, Inc.'s (TSE:3695) 25% Share Price Surge Not Quite Adding UpGMO Research & AI, Inc. ( TSE:3695 ) shares have had a really impressive month, gaining 25% after a shaky period...분석 기사 • Feb 13Subdued Growth No Barrier To GMO Research & AI, Inc. (TSE:3695) With Shares Advancing 25%GMO Research & AI, Inc. ( TSE:3695 ) shares have had a really impressive month, gaining 25% after a shaky period...New Risk • Feb 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (127% payout ratio). Share price has been volatile over the past 3 months (7.5% average weekly change). Profit margins are more than 30% lower than last year (3.0% net profit margin). Market cap is less than US$100m (JP¥4.69b market cap, or US$30.5m).Valuation Update With 7 Day Price Move • Feb 13Investor sentiment improves as stock rises 20%After last week's 20% share price gain to JP¥2,870, the stock trades at a trailing P/E ratio of 31.7x. Average trailing P/E is 17x in the Media industry in Japan. Total returns to shareholders of 38% over the past three years.공시 • Feb 12GMO Research & AI, Inc., Annual General Meeting, Mar 18, 2025GMO Research & AI, Inc., Annual General Meeting, Mar 18, 2025.Upcoming Dividend • Dec 20Upcoming dividend of JP¥115 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 24 March 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 4.2%. Within top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (2.3%).공시 • Dec 14GMO Research & AI, Inc. to Report Fiscal Year 2024 Results on Feb 12, 2025GMO Research & AI, Inc. announced that they will report fiscal year 2024 results on Feb 12, 2025Reported Earnings • Nov 08Third quarter 2024 earnings released: JP¥8.57 loss per share (vs JP¥38.59 profit in 3Q 2023)Third quarter 2024 results: JP¥8.57 loss per share (down from JP¥38.59 profit in 3Q 2023). Revenue: JP¥1.19b (down 2.3% from 3Q 2023). Net loss: JP¥14.0m (down 122% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.공시 • Sep 27GMO Research & AI, Inc. to Report Q3, 2024 Results on Nov 06, 2024GMO Research & AI, Inc. announced that they will report Q3, 2024 results on Nov 06, 2024분석 기사 • Aug 22Investors Can Find Comfort In GMO Research & AI's (TSE:3695) Earnings QualitySoft earnings didn't appear to concern GMO Research & AI, Inc.'s ( TSE:3695 ) shareholders over the last week. We did...Reported Earnings • Aug 09Second quarter 2024 earnings released: JP¥12.24 loss per share (vs JP¥11.64 profit in 2Q 2023)Second quarter 2024 results: JP¥12.24 loss per share (down from JP¥11.64 profit in 2Q 2023). Revenue: JP¥1.10b (down 4.3% from 2Q 2023). Net loss: JP¥20.0m (down 205% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has remained flat, which means it is well ahead of earnings.분석 기사 • Aug 07GMO Research & AI, Inc. (TSE:3695) Investors Are Less Pessimistic Than ExpectedWhen close to half the companies in Japan have price-to-earnings ratios (or "P/E's") below 11x, you may consider GMO...Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to JP¥2,258, the stock trades at a trailing P/E ratio of 14x. Average trailing P/E is 16x in the Media industry in Japan. Total returns to shareholders of 7.6% over the past three years.공시 • Jun 28GMO Research & AI, Inc. to Report Q2, 2024 Results on Aug 06, 2024GMO Research & AI, Inc. announced that they will report Q2, 2024 results on Aug 06, 2024Reported Earnings • May 09First quarter 2024 earnings released: EPS: JP¥56.31 (vs JP¥82.69 in 1Q 2023)First quarter 2024 results: EPS: JP¥56.31 (down from JP¥82.69 in 1Q 2023). Revenue: JP¥1.36b (down 4.6% from 1Q 2023). Net income: JP¥92.0m (down 32% from 1Q 2023). Profit margin: 6.8% (down from 9.5% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.공시 • Mar 17GMO Research, Inc. to Report Q1, 2024 Results on May 08, 2024GMO Research, Inc. announced that they will report Q1, 2024 results on May 08, 2024Reported Earnings • Feb 07Full year 2023 earnings released: EPS: JP¥188 (vs JP¥218 in FY 2022)Full year 2023 results: EPS: JP¥188 (down from JP¥218 in FY 2022). Revenue: JP¥5.12b (down 1.6% from FY 2022). Net income: JP¥307.0m (down 14% from FY 2022). Profit margin: 6.0% (down from 6.8% in FY 2022). Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 16% per year, which means it is tracking significantly ahead of earnings growth.공시 • Feb 07GMO Research, Inc., Annual General Meeting, Mar 18, 2024GMO Research, Inc., Annual General Meeting, Mar 18, 2024.공시 • Dec 28GMO Research, Inc. to Report Fiscal Year 2023 Results on Feb 05, 2024GMO Research, Inc. announced that they will report fiscal year 2023 results on Feb 05, 2024Upcoming Dividend • Dec 21Upcoming dividend of JP¥115 per share at 4.0% yieldEligible shareholders must have bought the stock before 28 December 2023. Payment date: 25 March 2024. Payout ratio is a comfortable 70% but the company is not cash flow positive. Trailing yield: 4.0%. Within top quartile of Japanese dividend payers (3.5%). Higher than average of industry peers (2.7%).Reported Earnings • Nov 07Third quarter 2023 earnings released: EPS: JP¥38.59 (vs JP¥44.12 in 3Q 2022)Third quarter 2023 results: EPS: JP¥38.59 (down from JP¥44.12 in 3Q 2022). Revenue: JP¥1.22b (flat on 3Q 2022). Net income: JP¥63.0m (down 13% from 3Q 2022). Profit margin: 5.2% (down from 5.9% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 15% per year and the company’s share price has also increased by 15% per year.공시 • Sep 17GMO Research, Inc. to Report Q3, 2023 Results on Nov 06, 2023GMO Research, Inc. announced that they will report Q3, 2023 results on Nov 06, 2023New Risk • Aug 14New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 52% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (52% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (5.0% net profit margin). Market cap is less than US$100m (JP¥4.59b market cap, or US$31.7m).New Risk • Aug 05New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 5.0% Last year net profit margin: 8.2% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (469% cash payout ratio). Profit margins are more than 30% lower than last year (5.0% net profit margin). Market cap is less than US$100m (JP¥4.83b market cap, or US$34.1m).Reported Earnings • Aug 04Second quarter 2023 earnings released: EPS: JP¥11.64 (vs JP¥43.51 in 2Q 2022)Second quarter 2023 results: EPS: JP¥11.64 (down from JP¥43.51 in 2Q 2022). Revenue: JP¥1.15b (down 2.7% from 2Q 2022). Net income: JP¥19.0m (down 73% from 2Q 2022). Profit margin: 1.6% (down from 6.0% in 2Q 2022). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 21% per year.공시 • Jun 28GMO Research, Inc. to Report Q2, 2023 Results on Aug 03, 2023GMO Research, Inc. announced that they will report Q2, 2023 results on Aug 03, 2023Reported Earnings • May 10First quarter 2023 earnings released: EPS: JP¥82.69 (vs JP¥107 in 1Q 2022)First quarter 2023 results: EPS: JP¥82.69 (down from JP¥107 in 1Q 2022). Revenue: JP¥1.43b (up 4.5% from 1Q 2022). Net income: JP¥135.0m (down 23% from 1Q 2022). Profit margin: 9.5% (down from 13% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 35% per year whereas the company’s share price has increased by 31% per year.Reported Earnings • Mar 28Full year 2022 earnings released: EPS: JP¥218 (vs JP¥168 in FY 2021)Full year 2022 results: EPS: JP¥218 (up from JP¥168 in FY 2021). Revenue: JP¥5.20b (up 27% from FY 2021). Net income: JP¥356.0m (up 30% from FY 2021). Profit margin: 6.8% (up from 6.7% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year whereas the company’s share price has increased by 45% per year.Valuation Update With 7 Day Price Move • Feb 13Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to JP¥3,060, the stock trades at a trailing P/E ratio of 14x. Average trailing P/E is 14x in the Media industry in Japan. Total returns to shareholders of 121% over the past three years.Reported Earnings • Feb 12Full year 2022 earnings released: EPS: JP¥218 (vs JP¥168 in FY 2021)Full year 2022 results: EPS: JP¥218 (up from JP¥168 in FY 2021). Revenue: JP¥5.20b (up 27% from FY 2021). Net income: JP¥356.0m (up 30% from FY 2021). Profit margin: 6.8% (up from 6.7% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth.공시 • Feb 08GMO Research, Inc., Annual General Meeting, Mar 22, 2023GMO Research, Inc., Annual General Meeting, Mar 22, 2023.Upcoming Dividend • Dec 22Upcoming dividend of JP¥116 per shareEligible shareholders must have bought the stock before 29 December 2022. Payment date: 22 March 2023. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.8%). In line with average of industry peers (2.7%).공시 • Dec 17GMO Research, Inc. to Report Fiscal Year 2022 Results on Feb 06, 2023GMO Research, Inc. announced that they will report fiscal year 2022 results on Feb 06, 2023Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 5 highly experienced directors. No independent directors (8 non-independent directors). Director Masashi Yasuda was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Nov 09Third quarter 2022 earnings released: EPS: JP¥44.12 (vs JP¥28.82 in 3Q 2021)Third quarter 2022 results: EPS: JP¥44.12 (up from JP¥28.82 in 3Q 2021). Revenue: JP¥1.22b (up 22% from 3Q 2021). Net income: JP¥72.0m (up 53% from 3Q 2021). Profit margin: 5.9% (up from 4.7% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth.공시 • Sep 18GMO Research, Inc. to Report Q3, 2022 Results on Nov 07, 2022GMO Research, Inc. announced that they will report Q3, 2022 results on Nov 07, 2022Valuation Update With 7 Day Price Move • Aug 11Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to JP¥3,740, the stock trades at a trailing P/E ratio of 15.6x. Average trailing P/E is 15x in the Media industry in Japan. Total returns to shareholders of 116% over the past three years.Reported Earnings • Aug 05Second quarter 2022 earnings released: EPS: JP¥43.51 (vs JP¥14.11 in 2Q 2021)Second quarter 2022 results: EPS: JP¥43.51 (up from JP¥14.11 in 2Q 2021). Revenue: JP¥1.19b (up 33% from 2Q 2021). Net income: JP¥71.0m (up 209% from 2Q 2021). Profit margin: 6.0% (up from 2.6% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth.공시 • Jun 29GMO Research, Inc. to Report Q2, 2022 Results on Aug 04, 2022GMO Research, Inc. announced that they will report Q2, 2022 results on Aug 04, 2022Valuation Update With 7 Day Price Move • Jun 17Investor sentiment improved over the past weekAfter last week's 22% share price gain to JP¥4,080, the stock trades at a trailing P/E ratio of 19.4x. Average trailing P/E is 13x in the Media industry in Japan. Total returns to shareholders of 148% over the past three years.Valuation Update With 7 Day Price Move • May 30Investor sentiment improved over the past weekAfter last week's 21% share price gain to JP¥3,095, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 14x in the Media industry in Japan. Total returns to shareholders of 109% over the past three years.공시 • May 12GMO Research, Inc. to Report Q1, 2022 Results on May 09, 2022GMO Research, Inc. announced that they will report Q1, 2022 results on May 09, 2022Reported Earnings • May 11First quarter 2022 earnings released: EPS: JP¥107 (vs JP¥64.39 in 1Q 2021)First quarter 2022 results: EPS: JP¥107 (up from JP¥64.39 in 1Q 2021). Revenue: JP¥1.37b (up 40% from 1Q 2021). Net income: JP¥175.0m (up 67% from 1Q 2021). Profit margin: 13% (up from 11% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 5 highly experienced directors. No independent directors (8 non-independent directors). Director Masashi Yasuda was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.공시 • Feb 09GMO Research, Inc., Annual General Meeting, Mar 18, 2022GMO Research, Inc., Annual General Meeting, Mar 18, 2022.Reported Earnings • Feb 08Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: JP¥168 (up from JP¥107 in FY 2020). Revenue: JP¥4.09b (up 20% from FY 2020). Net income: JP¥274.0m (up 57% from FY 2020). Profit margin: 6.7% (up from 5.2% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • Dec 22Upcoming dividend of JP¥73.53 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 22 March 2022. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (1.9%).Reported Earnings • Nov 10Third quarter 2021 earnings released: EPS JP¥28.82 (vs JP¥25.76 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: JP¥999.0m (up 27% from 3Q 2020). Net income: JP¥47.0m (up 12% from 3Q 2020). Profit margin: 4.7% (down from 5.3% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jun 24Investor sentiment improved over the past weekAfter last week's 18% share price gain to JP¥2,603, the stock trades at a trailing P/E ratio of 17x. Average trailing P/E is 24x in the Media industry in Japan. Total returns to shareholders of 66% over the past three years.Reported Earnings • May 08First quarter 2021 earnings released: EPS JP¥64.39 (vs JP¥19.01 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: JP¥976.0m (up 6.7% from 1Q 2020). Net income: JP¥105.0m (up 239% from 1Q 2020). Profit margin: 11% (up from 3.4% in 1Q 2020). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • May 07Investor sentiment improved over the past weekAfter last week's 15% share price gain to JP¥2,050, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 23x in the Media industry in Japan. Total returns to shareholders of 18% over the past three years.공시 • Apr 29GMO Research, Inc. to launch new service brand “MO Lite”GMO Research, Inc. has rolled out a new initiative to support companies in conducting online research projects with the fastest and most cost-effective turnaround in APAC. There is an increasing demand for DIY market research tools that allow companies to conduct survey research remotely and at low costs. But when a company really starts to plan a research project, there are some common obstacles. Firstly, the targeted audience is limited to the company’s own service and/or product line, so the company cannot collect a larger number of responses. Secondly, recruiting people for a survey is a time-consuming and costly process. And lastly, localizing questionnaires, ensuring they align with local law, and checking that the contents address the cultural and linguistic background correctly takes a great deal of effort. To address these issues, GMO Research has developed “MO Lite”, a new service that enables companies to link their own using DIY market research tools to recruit survey respondents directly from one of the largest pool of panelists in APAC, with a price less as USD 10 cent per question, that comes with full support from APAC local experts. USD 300 minimum fee will be included.공시 • Feb 11GMO Research, Inc., Annual General Meeting, Mar 19, 2021GMO Research, Inc., Annual General Meeting, Mar 19, 2021.Reported Earnings • Feb 11Full year 2020 earnings released: EPS JP¥107 (vs JP¥83.74 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: JP¥3.39b (up 3.2% from FY 2019). Net income: JP¥175.0m (up 28% from FY 2019). Profit margin: 5.2% (up from 4.2% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year whereas the company’s share price has fallen by 1% per year.Is New 90 Day High Low • Dec 29New 90-day low: JP¥1,645The company is down 3.0% from its price of JP¥1,702 on 30 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Media industry, which is up 2.0% over the same period.공시 • Oct 04GMO Research, Inc. to Report Q3, 2020 Results on Nov 06, 2020GMO Research, Inc. announced that they will report Q3, 2020 results on Nov 06, 2020공시 • Jun 28GMO Research, Inc. to Report Q2, 2020 Results on Aug 07, 2020GMO Research, Inc. announced that they will report Q2, 2020 results on Aug 07, 2020주주 수익률3695JP MediaJP 시장7D-1.2%-2.1%4.2%1Y-34.9%-0.6%44.4%전체 주주 수익률 보기수익률 대 산업: 3695은 지난 1년 동안 -0.6%의 수익을 기록한 JP Media 산업보다 저조한 성과를 냈습니다.수익률 대 시장: 3695은 지난 1년 동안 44.4%를 기록한 JP 시장보다 저조한 성과를 냈습니다.주가 변동성Is 3695's price volatile compared to industry and market?3695 volatility3695 Average Weekly Movement3.4%Media Industry Average Movement4.7%Market Average Movement4.6%10% most volatile stocks in JP Market9.4%10% least volatile stocks in JP Market2.4%안정적인 주가: 3695는 지난 3개월 동안 JP 시장에 비해 주가 변동성이 크지 않았습니다.시간에 따른 변동성: 3695의 주간 변동성(3%)은 지난 1년 동안 안정적이었습니다.회사 소개설립직원 수CEO웹사이트2002199Takehiro Ogitagmo-research.ai는 일본, 아시아 및 전 세계에 오디언스 참여 플랫폼을 제공합니다. 이 회사의 오디언스 참여 플랫폼은 다중 패널 및 다국가 온라인 패널 네트워크인 아시아 클라우드 패널에 대한 액세스를 제공합니다. 또한 빠른 맞춤형 설문조사 서비스도 제공합니다.더 보기GMO Product Platform, Inc. 기초 지표 요약GMO Product Platform의 순이익과 매출은 시가총액과 어떻게 비교됩니까?3695 기초 통계시가총액JP¥7.14b순이익 (TTM)JP¥414.00m매출 (TTM)JP¥7.50b17.2x주가수익비율(P/E)0.9x주가매출비율(P/S)3695는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표3695 손익계산서 (TTM)매출JP¥7.50b매출원가JP¥3.08b총이익JP¥4.41b기타 비용JP¥4.00b순이익JP¥414.00m최근 보고된 실적Mar 31, 2026다음 실적 발표일해당 없음주당순이익(EPS)94.02총이익률58.86%순이익률5.52%부채/자본 비율25.6%3695의 장기 실적은 어땠습니까?과거 실적 및 비교 보기배당4.0%현재 배당 수익률63%배당 성향View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/16 15:24종가2026/06/16 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스GMO Product Platform, Inc.는 3명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Yu TokudaDaiwa Securities Co. Ltd.Kaname FujitaIchiyoshi Research Institute Inc.Ikuo ShibataThe Stock Research Center
Reported Earnings • May 13First quarter 2026 earnings released: EPS: JP¥43.61 (vs JP¥41.01 loss in 1Q 2025)First quarter 2026 results: EPS: JP¥43.61 (up from JP¥41.01 loss in 1Q 2025). Revenue: JP¥2.00b (up 52% from 1Q 2025). Net income: JP¥192.0m (up JP¥259.0m from 1Q 2025). Profit margin: 9.6% (up from net loss in 1Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Feb 17Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to JP¥1,706, the stock trades at a trailing P/E ratio of 48.5x. Average trailing P/E is 16x in the Media industry in Japan. Total loss to shareholders of 38% over the past three years.
New Risk • Feb 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (170% increase in shares outstanding). Minor Risks Dividend is not well covered by earnings (158% payout ratio). Share price has been volatile over the past 3 months (5.5% average weekly change). Profit margins are more than 30% lower than last year (2.3% net profit margin). Market cap is less than US$100m (JP¥8.10b market cap, or US$52.8m).
Reported Earnings • Feb 11Full year 2025 earnings released: EPS: JP¥41.66 (vs JP¥112 in FY 2024)Full year 2025 results: EPS: JP¥41.66 (down from JP¥112 in FY 2024). Revenue: JP¥6.82b (up 36% from FY 2024). Net income: JP¥155.0m (down 15% from FY 2024). Profit margin: 2.3% (down from 3.6% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.
New Risk • Feb 11New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.3% Last year net profit margin: 3.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (170% increase in shares outstanding). Minor Risks Dividend is not well covered by earnings (158% payout ratio). Profit margins are more than 30% lower than last year (2.3% net profit margin). Market cap is less than US$100m (JP¥9.03b market cap, or US$59.0m).
공시 • Feb 10GMO Product Platform, Inc., Annual General Meeting, Mar 17, 2026GMO Product Platform, Inc., Annual General Meeting, Mar 17, 2026.
Reported Earnings • May 13First quarter 2026 earnings released: EPS: JP¥43.61 (vs JP¥41.01 loss in 1Q 2025)First quarter 2026 results: EPS: JP¥43.61 (up from JP¥41.01 loss in 1Q 2025). Revenue: JP¥2.00b (up 52% from 1Q 2025). Net income: JP¥192.0m (up JP¥259.0m from 1Q 2025). Profit margin: 9.6% (up from net loss in 1Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Feb 17Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to JP¥1,706, the stock trades at a trailing P/E ratio of 48.5x. Average trailing P/E is 16x in the Media industry in Japan. Total loss to shareholders of 38% over the past three years.
New Risk • Feb 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (170% increase in shares outstanding). Minor Risks Dividend is not well covered by earnings (158% payout ratio). Share price has been volatile over the past 3 months (5.5% average weekly change). Profit margins are more than 30% lower than last year (2.3% net profit margin). Market cap is less than US$100m (JP¥8.10b market cap, or US$52.8m).
Reported Earnings • Feb 11Full year 2025 earnings released: EPS: JP¥41.66 (vs JP¥112 in FY 2024)Full year 2025 results: EPS: JP¥41.66 (down from JP¥112 in FY 2024). Revenue: JP¥6.82b (up 36% from FY 2024). Net income: JP¥155.0m (down 15% from FY 2024). Profit margin: 2.3% (down from 3.6% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.
New Risk • Feb 11New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.3% Last year net profit margin: 3.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (170% increase in shares outstanding). Minor Risks Dividend is not well covered by earnings (158% payout ratio). Profit margins are more than 30% lower than last year (2.3% net profit margin). Market cap is less than US$100m (JP¥9.03b market cap, or US$59.0m).
공시 • Feb 10GMO Product Platform, Inc., Annual General Meeting, Mar 17, 2026GMO Product Platform, Inc., Annual General Meeting, Mar 17, 2026.
공시 • Dec 27GMO Product Platform, Inc. to Report Fiscal Year 2025 Results on Feb 10, 2026GMO Product Platform, Inc. announced that they will report fiscal year 2025 results on Feb 10, 2026
Upcoming Dividend • Dec 22Upcoming dividend of JP¥34.58 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 23 March 2026. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 1.6%. Lower than top quartile of Japanese dividend payers (3.6%). In line with average of industry peers (1.7%).
공시 • Dec 17GMO Product Platform, Inc. (TSE:3695) agreed to acquire 53.60% stake in STOCK POINT Inc. from Credit Saison Co., Ltd. (TSE:8253), KITS Co., Ltd and Kiyomi Tsuchiya for approximately ¥360 million.GMO Product Platform, Inc. (TSE:3695) agreed to acquire 53.60% stake in STOCK POINT Inc. from Credit Saison Co., Ltd. (TSE:8253), KITS Co., Ltd and Kiyomi Tsuchiya for approximately ¥360 million on December 15, 2025. A cash consideration of ¥361 million will be paid by GMO Product Platform, Inc. The scheduled contract execution date is December 16, 2025. Prior to the share transfer execution date, we may acquire additional shares of STOCK POINT Inc. held by other individuals and corporations. In this case, the maximum acquisition price will be ¥564 million, and the maximum number of shares to be acquired will be 1,324 shares and the maximum ownership ratio will be 82.5%. Additional disclosure is planned once the acquisition price and number of shares for the additional acquisition are finalized. For the period ending March 31, 2025, STOCK POINT Inc. reported total revenue of ¥374.18 million, operating loss of ¥231.81 million and net income of ¥200.21 million. As of March 31, 2025, STOCK POINT Inc. reported total assets of ¥2.28 billion and total common equity of ¥214.51 million. The expected completion of the transaction is December 26, 2025.
Buy Or Sell Opportunity • Dec 04Now 21% overvaluedOver the last 90 days, the stock has fallen 2.4% to JP¥2,159. The fair value is estimated to be JP¥1,782, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.4% over the last 3 years. Earnings per share has declined by 48%.
Reported Earnings • Nov 15Third quarter 2025 earnings released: EPS: JP¥23.99 (vs JP¥8.57 loss in 3Q 2024)Third quarter 2025 results: EPS: JP¥23.99 (up from JP¥8.57 loss in 3Q 2024). Revenue: JP¥1.75b (up 47% from 3Q 2024). Net income: JP¥106.0m (up JP¥120.0m from 3Q 2024). Profit margin: 6.1% (up from net loss in 3Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.
공시 • Sep 17GMO Research & AI, Inc. to Report Q3, 2025 Results on Nov 12, 2025GMO Research & AI, Inc. announced that they will report Q3, 2025 results on Nov 12, 2025
Reported Earnings • Aug 08Second quarter 2025 earnings released: EPS: JP¥12.67 (vs JP¥12.24 loss in 2Q 2024)Second quarter 2025 results: EPS: JP¥12.67 (up from JP¥12.24 loss in 2Q 2024). Revenue: JP¥1.85b (up 68% from 2Q 2024). Net income: JP¥56.0m (up JP¥76.0m from 2Q 2024). Profit margin: 3.0% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.
공시 • Jun 27GMO Research & AI, Inc. to Report Q2, 2025 Results on Aug 07, 2025GMO Research & AI, Inc. announced that they will report Q2, 2025 results on Aug 07, 2025
New Risk • May 17New major risk - Revenue and earnings growthEarnings have declined by 0.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Dividend per share is over 7x earnings per share. Cash payout ratio: 447% Earnings have declined by 0.4% per year over the past 5 years. Shareholders have been substantially diluted in the past year (169% increase in shares outstanding). Minor Risks Profit margins are more than 30% lower than last year (0.5% net profit margin). Market cap is less than US$100m (JP¥11.1b market cap, or US$76.0m).
Reported Earnings • May 17First quarter 2025 earnings released: JP¥41.01 loss per share (vs JP¥56.35 profit in 1Q 2024)First quarter 2025 results: JP¥41.01 loss per share (down from JP¥56.35 profit in 1Q 2024). Revenue: JP¥1.32b (down 3.2% from 1Q 2024). Net loss: JP¥67.0m (down 173% from profit in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • May 15Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to JP¥2,374, the stock trades at a trailing P/E ratio of 57.1x. Average trailing P/E is 17x in the Media industry in Japan. Total returns to shareholders of 4.5% over the past three years.
New Risk • Apr 18New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 169% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 103% Cash payout ratio: 447% Shareholders have been substantially diluted in the past year (169% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Profit margins are more than 30% lower than last year (3.6% net profit margin). Market cap is less than US$100m (JP¥12.2b market cap, or US$85.7m).
분석 기사 • Apr 09Returns On Capital At GMO Research & AI (TSE:3695) Paint A Concerning PictureWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...
공시 • Mar 08GMO Research & AI, Inc. to Report Q1, 2025 Results on May 12, 2025GMO Research & AI, Inc. announced that they will report Q1, 2025 results on May 12, 2025
New Risk • Feb 15New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 127% Cash payout ratio: 166% Dividend yield: 4.1% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.6% average weekly change). Dividend is not well covered by earnings and cash flows. Payout ratio: 127% Cash payout ratio: 166% Minor Risks Profit margins are more than 30% lower than last year (3.6% net profit margin). Market cap is less than US$100m (JP¥4.57b market cap, or US$30.0m).
Reported Earnings • Feb 14Full year 2024 earnings released: EPS: JP¥112 (vs JP¥188 in FY 2023)Full year 2024 results: EPS: JP¥112 (down from JP¥188 in FY 2023). Revenue: JP¥5.03b (down 1.8% from FY 2023). Net income: JP¥183.0m (down 40% from FY 2023). Profit margin: 3.6% (down from 6.0% in FY 2023). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.
분석 기사 • Feb 13GMO Research & AI, Inc.'s (TSE:3695) 25% Share Price Surge Not Quite Adding UpGMO Research & AI, Inc. ( TSE:3695 ) shares have had a really impressive month, gaining 25% after a shaky period...
분석 기사 • Feb 13Subdued Growth No Barrier To GMO Research & AI, Inc. (TSE:3695) With Shares Advancing 25%GMO Research & AI, Inc. ( TSE:3695 ) shares have had a really impressive month, gaining 25% after a shaky period...
New Risk • Feb 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (127% payout ratio). Share price has been volatile over the past 3 months (7.5% average weekly change). Profit margins are more than 30% lower than last year (3.0% net profit margin). Market cap is less than US$100m (JP¥4.69b market cap, or US$30.5m).
Valuation Update With 7 Day Price Move • Feb 13Investor sentiment improves as stock rises 20%After last week's 20% share price gain to JP¥2,870, the stock trades at a trailing P/E ratio of 31.7x. Average trailing P/E is 17x in the Media industry in Japan. Total returns to shareholders of 38% over the past three years.
공시 • Feb 12GMO Research & AI, Inc., Annual General Meeting, Mar 18, 2025GMO Research & AI, Inc., Annual General Meeting, Mar 18, 2025.
Upcoming Dividend • Dec 20Upcoming dividend of JP¥115 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 24 March 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 4.2%. Within top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (2.3%).
공시 • Dec 14GMO Research & AI, Inc. to Report Fiscal Year 2024 Results on Feb 12, 2025GMO Research & AI, Inc. announced that they will report fiscal year 2024 results on Feb 12, 2025
Reported Earnings • Nov 08Third quarter 2024 earnings released: JP¥8.57 loss per share (vs JP¥38.59 profit in 3Q 2023)Third quarter 2024 results: JP¥8.57 loss per share (down from JP¥38.59 profit in 3Q 2023). Revenue: JP¥1.19b (down 2.3% from 3Q 2023). Net loss: JP¥14.0m (down 122% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
공시 • Sep 27GMO Research & AI, Inc. to Report Q3, 2024 Results on Nov 06, 2024GMO Research & AI, Inc. announced that they will report Q3, 2024 results on Nov 06, 2024
분석 기사 • Aug 22Investors Can Find Comfort In GMO Research & AI's (TSE:3695) Earnings QualitySoft earnings didn't appear to concern GMO Research & AI, Inc.'s ( TSE:3695 ) shareholders over the last week. We did...
Reported Earnings • Aug 09Second quarter 2024 earnings released: JP¥12.24 loss per share (vs JP¥11.64 profit in 2Q 2023)Second quarter 2024 results: JP¥12.24 loss per share (down from JP¥11.64 profit in 2Q 2023). Revenue: JP¥1.10b (down 4.3% from 2Q 2023). Net loss: JP¥20.0m (down 205% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
분석 기사 • Aug 07GMO Research & AI, Inc. (TSE:3695) Investors Are Less Pessimistic Than ExpectedWhen close to half the companies in Japan have price-to-earnings ratios (or "P/E's") below 11x, you may consider GMO...
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to JP¥2,258, the stock trades at a trailing P/E ratio of 14x. Average trailing P/E is 16x in the Media industry in Japan. Total returns to shareholders of 7.6% over the past three years.
공시 • Jun 28GMO Research & AI, Inc. to Report Q2, 2024 Results on Aug 06, 2024GMO Research & AI, Inc. announced that they will report Q2, 2024 results on Aug 06, 2024
Reported Earnings • May 09First quarter 2024 earnings released: EPS: JP¥56.31 (vs JP¥82.69 in 1Q 2023)First quarter 2024 results: EPS: JP¥56.31 (down from JP¥82.69 in 1Q 2023). Revenue: JP¥1.36b (down 4.6% from 1Q 2023). Net income: JP¥92.0m (down 32% from 1Q 2023). Profit margin: 6.8% (down from 9.5% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.
공시 • Mar 17GMO Research, Inc. to Report Q1, 2024 Results on May 08, 2024GMO Research, Inc. announced that they will report Q1, 2024 results on May 08, 2024
Reported Earnings • Feb 07Full year 2023 earnings released: EPS: JP¥188 (vs JP¥218 in FY 2022)Full year 2023 results: EPS: JP¥188 (down from JP¥218 in FY 2022). Revenue: JP¥5.12b (down 1.6% from FY 2022). Net income: JP¥307.0m (down 14% from FY 2022). Profit margin: 6.0% (down from 6.8% in FY 2022). Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 16% per year, which means it is tracking significantly ahead of earnings growth.
공시 • Feb 07GMO Research, Inc., Annual General Meeting, Mar 18, 2024GMO Research, Inc., Annual General Meeting, Mar 18, 2024.
공시 • Dec 28GMO Research, Inc. to Report Fiscal Year 2023 Results on Feb 05, 2024GMO Research, Inc. announced that they will report fiscal year 2023 results on Feb 05, 2024
Upcoming Dividend • Dec 21Upcoming dividend of JP¥115 per share at 4.0% yieldEligible shareholders must have bought the stock before 28 December 2023. Payment date: 25 March 2024. Payout ratio is a comfortable 70% but the company is not cash flow positive. Trailing yield: 4.0%. Within top quartile of Japanese dividend payers (3.5%). Higher than average of industry peers (2.7%).
Reported Earnings • Nov 07Third quarter 2023 earnings released: EPS: JP¥38.59 (vs JP¥44.12 in 3Q 2022)Third quarter 2023 results: EPS: JP¥38.59 (down from JP¥44.12 in 3Q 2022). Revenue: JP¥1.22b (flat on 3Q 2022). Net income: JP¥63.0m (down 13% from 3Q 2022). Profit margin: 5.2% (down from 5.9% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 15% per year and the company’s share price has also increased by 15% per year.
공시 • Sep 17GMO Research, Inc. to Report Q3, 2023 Results on Nov 06, 2023GMO Research, Inc. announced that they will report Q3, 2023 results on Nov 06, 2023
New Risk • Aug 14New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 52% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (52% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (5.0% net profit margin). Market cap is less than US$100m (JP¥4.59b market cap, or US$31.7m).
New Risk • Aug 05New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 5.0% Last year net profit margin: 8.2% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (469% cash payout ratio). Profit margins are more than 30% lower than last year (5.0% net profit margin). Market cap is less than US$100m (JP¥4.83b market cap, or US$34.1m).
Reported Earnings • Aug 04Second quarter 2023 earnings released: EPS: JP¥11.64 (vs JP¥43.51 in 2Q 2022)Second quarter 2023 results: EPS: JP¥11.64 (down from JP¥43.51 in 2Q 2022). Revenue: JP¥1.15b (down 2.7% from 2Q 2022). Net income: JP¥19.0m (down 73% from 2Q 2022). Profit margin: 1.6% (down from 6.0% in 2Q 2022). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 21% per year.
공시 • Jun 28GMO Research, Inc. to Report Q2, 2023 Results on Aug 03, 2023GMO Research, Inc. announced that they will report Q2, 2023 results on Aug 03, 2023
Reported Earnings • May 10First quarter 2023 earnings released: EPS: JP¥82.69 (vs JP¥107 in 1Q 2022)First quarter 2023 results: EPS: JP¥82.69 (down from JP¥107 in 1Q 2022). Revenue: JP¥1.43b (up 4.5% from 1Q 2022). Net income: JP¥135.0m (down 23% from 1Q 2022). Profit margin: 9.5% (down from 13% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 35% per year whereas the company’s share price has increased by 31% per year.
Reported Earnings • Mar 28Full year 2022 earnings released: EPS: JP¥218 (vs JP¥168 in FY 2021)Full year 2022 results: EPS: JP¥218 (up from JP¥168 in FY 2021). Revenue: JP¥5.20b (up 27% from FY 2021). Net income: JP¥356.0m (up 30% from FY 2021). Profit margin: 6.8% (up from 6.7% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year whereas the company’s share price has increased by 45% per year.
Valuation Update With 7 Day Price Move • Feb 13Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to JP¥3,060, the stock trades at a trailing P/E ratio of 14x. Average trailing P/E is 14x in the Media industry in Japan. Total returns to shareholders of 121% over the past three years.
Reported Earnings • Feb 12Full year 2022 earnings released: EPS: JP¥218 (vs JP¥168 in FY 2021)Full year 2022 results: EPS: JP¥218 (up from JP¥168 in FY 2021). Revenue: JP¥5.20b (up 27% from FY 2021). Net income: JP¥356.0m (up 30% from FY 2021). Profit margin: 6.8% (up from 6.7% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth.
공시 • Feb 08GMO Research, Inc., Annual General Meeting, Mar 22, 2023GMO Research, Inc., Annual General Meeting, Mar 22, 2023.
Upcoming Dividend • Dec 22Upcoming dividend of JP¥116 per shareEligible shareholders must have bought the stock before 29 December 2022. Payment date: 22 March 2023. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.8%). In line with average of industry peers (2.7%).
공시 • Dec 17GMO Research, Inc. to Report Fiscal Year 2022 Results on Feb 06, 2023GMO Research, Inc. announced that they will report fiscal year 2022 results on Feb 06, 2023
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 5 highly experienced directors. No independent directors (8 non-independent directors). Director Masashi Yasuda was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Nov 09Third quarter 2022 earnings released: EPS: JP¥44.12 (vs JP¥28.82 in 3Q 2021)Third quarter 2022 results: EPS: JP¥44.12 (up from JP¥28.82 in 3Q 2021). Revenue: JP¥1.22b (up 22% from 3Q 2021). Net income: JP¥72.0m (up 53% from 3Q 2021). Profit margin: 5.9% (up from 4.7% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth.
공시 • Sep 18GMO Research, Inc. to Report Q3, 2022 Results on Nov 07, 2022GMO Research, Inc. announced that they will report Q3, 2022 results on Nov 07, 2022
Valuation Update With 7 Day Price Move • Aug 11Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to JP¥3,740, the stock trades at a trailing P/E ratio of 15.6x. Average trailing P/E is 15x in the Media industry in Japan. Total returns to shareholders of 116% over the past three years.
Reported Earnings • Aug 05Second quarter 2022 earnings released: EPS: JP¥43.51 (vs JP¥14.11 in 2Q 2021)Second quarter 2022 results: EPS: JP¥43.51 (up from JP¥14.11 in 2Q 2021). Revenue: JP¥1.19b (up 33% from 2Q 2021). Net income: JP¥71.0m (up 209% from 2Q 2021). Profit margin: 6.0% (up from 2.6% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth.
공시 • Jun 29GMO Research, Inc. to Report Q2, 2022 Results on Aug 04, 2022GMO Research, Inc. announced that they will report Q2, 2022 results on Aug 04, 2022
Valuation Update With 7 Day Price Move • Jun 17Investor sentiment improved over the past weekAfter last week's 22% share price gain to JP¥4,080, the stock trades at a trailing P/E ratio of 19.4x. Average trailing P/E is 13x in the Media industry in Japan. Total returns to shareholders of 148% over the past three years.
Valuation Update With 7 Day Price Move • May 30Investor sentiment improved over the past weekAfter last week's 21% share price gain to JP¥3,095, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 14x in the Media industry in Japan. Total returns to shareholders of 109% over the past three years.
공시 • May 12GMO Research, Inc. to Report Q1, 2022 Results on May 09, 2022GMO Research, Inc. announced that they will report Q1, 2022 results on May 09, 2022
Reported Earnings • May 11First quarter 2022 earnings released: EPS: JP¥107 (vs JP¥64.39 in 1Q 2021)First quarter 2022 results: EPS: JP¥107 (up from JP¥64.39 in 1Q 2021). Revenue: JP¥1.37b (up 40% from 1Q 2021). Net income: JP¥175.0m (up 67% from 1Q 2021). Profit margin: 13% (up from 11% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 5 highly experienced directors. No independent directors (8 non-independent directors). Director Masashi Yasuda was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
공시 • Feb 09GMO Research, Inc., Annual General Meeting, Mar 18, 2022GMO Research, Inc., Annual General Meeting, Mar 18, 2022.
Reported Earnings • Feb 08Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: JP¥168 (up from JP¥107 in FY 2020). Revenue: JP¥4.09b (up 20% from FY 2020). Net income: JP¥274.0m (up 57% from FY 2020). Profit margin: 6.7% (up from 5.2% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • Dec 22Upcoming dividend of JP¥73.53 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 22 March 2022. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (1.9%).
Reported Earnings • Nov 10Third quarter 2021 earnings released: EPS JP¥28.82 (vs JP¥25.76 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: JP¥999.0m (up 27% from 3Q 2020). Net income: JP¥47.0m (up 12% from 3Q 2020). Profit margin: 4.7% (down from 5.3% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jun 24Investor sentiment improved over the past weekAfter last week's 18% share price gain to JP¥2,603, the stock trades at a trailing P/E ratio of 17x. Average trailing P/E is 24x in the Media industry in Japan. Total returns to shareholders of 66% over the past three years.
Reported Earnings • May 08First quarter 2021 earnings released: EPS JP¥64.39 (vs JP¥19.01 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: JP¥976.0m (up 6.7% from 1Q 2020). Net income: JP¥105.0m (up 239% from 1Q 2020). Profit margin: 11% (up from 3.4% in 1Q 2020). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • May 07Investor sentiment improved over the past weekAfter last week's 15% share price gain to JP¥2,050, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 23x in the Media industry in Japan. Total returns to shareholders of 18% over the past three years.
공시 • Apr 29GMO Research, Inc. to launch new service brand “MO Lite”GMO Research, Inc. has rolled out a new initiative to support companies in conducting online research projects with the fastest and most cost-effective turnaround in APAC. There is an increasing demand for DIY market research tools that allow companies to conduct survey research remotely and at low costs. But when a company really starts to plan a research project, there are some common obstacles. Firstly, the targeted audience is limited to the company’s own service and/or product line, so the company cannot collect a larger number of responses. Secondly, recruiting people for a survey is a time-consuming and costly process. And lastly, localizing questionnaires, ensuring they align with local law, and checking that the contents address the cultural and linguistic background correctly takes a great deal of effort. To address these issues, GMO Research has developed “MO Lite”, a new service that enables companies to link their own using DIY market research tools to recruit survey respondents directly from one of the largest pool of panelists in APAC, with a price less as USD 10 cent per question, that comes with full support from APAC local experts. USD 300 minimum fee will be included.
공시 • Feb 11GMO Research, Inc., Annual General Meeting, Mar 19, 2021GMO Research, Inc., Annual General Meeting, Mar 19, 2021.
Reported Earnings • Feb 11Full year 2020 earnings released: EPS JP¥107 (vs JP¥83.74 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: JP¥3.39b (up 3.2% from FY 2019). Net income: JP¥175.0m (up 28% from FY 2019). Profit margin: 5.2% (up from 4.2% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year whereas the company’s share price has fallen by 1% per year.
Is New 90 Day High Low • Dec 29New 90-day low: JP¥1,645The company is down 3.0% from its price of JP¥1,702 on 30 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Media industry, which is up 2.0% over the same period.
공시 • Oct 04GMO Research, Inc. to Report Q3, 2020 Results on Nov 06, 2020GMO Research, Inc. announced that they will report Q3, 2020 results on Nov 06, 2020
공시 • Jun 28GMO Research, Inc. to Report Q2, 2020 Results on Aug 07, 2020GMO Research, Inc. announced that they will report Q2, 2020 results on Aug 07, 2020
